Prospective assessment of tumour burden and bone disease in plasma cell dyscrasias using DW-MRI and exploratory bone biomarkers
<p>Novel biomarkers for tumour burden and bone disease are required to guide clinical management of plasma cell dyscrasias. Recently, bone turnover markers (BTMs) and Diffusion-Weighted Magnetic Resonance Imaging (DW-MRI) have been explored, although their role in the prospective assessment of...
Main Authors: | , , , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Journal article |
Language: | English |
Published: |
MDPI
2022
|